Stockreport

Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF Completed enrollment with 530 subjects in the pivotal phase 3 PHOENIX trial in geographic atrophy (GA)Completed $15 million registered direct offering and $125 million p [Read more]